Insomnia News and Research

Latest Insomnia News and Research

Wide range of sleep-related disorders associated with abnormal sexual behaviors, experiences

A paper published in the June 1st issue of the journal SLEEP is the first literature review and formal classification of a wide range of documented sleep-related disorders associated with abnormal sexual behaviors and experiences.

3 Jun 2007

Daytrana provides significant effectiveness in both boys and girls with ADHD

Shire plc has announced that DAYTRANA (methylphenidate transdermal system), its Attention Deficit Hyperactivity Disorder (ADHD) patch, had significant efficacy in reducing the symptoms of ADHD in both male and female children aged 6 to 12 years, according to clinical trial results reported at the American Psychiatric Association (APA) annual meeting in San Diego.

24 May 2007

More evidence found indicating potassium channels play a critical role in sleep

A gene that controls the flow of potassium into cells is required to maintain normal sleep in fruit flies, according to researchers at the University of Wisconsin School of Medicine and Public Health (SMPH).

24 May 2007

Ramelteon does not impair balance, mobility or memory performance in older adults with insomnia

A new study presented today showed that ramelteon did not impair middle-of-the-night balance, mobility or memory performance in older adults with insomnia, relative to placebo.

24 May 2007

Efficacy and safety of Aripiprazole as adjunctive therapy in major depressive disorder

In adults with major depressive disorder, adding aripiprazole to antidepressant therapy (ADT) resulted in significant improvement in the primary endpoint, the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score.

24 May 2007

Link between Parkinson's and narcolepsy

Parkinson's disease is well-known for its progression of motor disorders: stiffness, slowness, tremors, difficulties walking and talking.

17 May 2007

Patch to treat Parkinson's gets FDA green light

The Food and Drug Administration (FDA) in the United States has given it's approval for the first patch for Parkinson's disease.

14 May 2007

FDA approves skin patch designed to treat symptoms of early Parkinson's disease

Rotigotine is a drug not previously approved in the United States. Neupro is the first transdermal patch approved for the treatment of symptoms of Parkinson's disease.

10 May 2007

New understanding of sleep

Sleep remains one of the big mysteries in biology. All animals sleep, and people who are deprived of sleep suffer physically, emotionally and intellectually. But nobody knows how sleep restores the brain.

1 May 2007

FDA approves INVEGA treatment for schizophrenia

The U.S. Food and Drug Administration (FDA) has approved INVEGA (paliperidone) Extended-Release Tablets, a new once-daily, atypical antipsychotic, for the long-term maintenance treatment of schizophrenia.

30 Apr 2007

Ranbaxy receives approval to manufacture Zolpidem tablets for insomnia

Ranbaxy Laboratories Limited (RLL), has announced that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Zolpidem Tartrate Tablets, 5mg and 10mg.

27 Apr 2007

ADHD study to look at effects of different stimulant medications and dosages on sleep and mood

Researchers at the University of Illinois at Chicago are comparing two common stimulant drugs with a placebo to evaluate their effect on sleep and behavior in children with attention deficit hyperactivity disorder.

25 Apr 2007

FDA approves generic versions of Ambien

The U.S. Food and Drug Administration (FDA) today approved the first generic versions of Ambien (zolpidem tartrate) immediate-release tablets.

24 Apr 2007

New findings on insomnia

Those persons who are labeled a 'night owl' report more pathological symptoms related to insomnia, despite many having the opportunity to compensate for their nocturnal sleeplessness by extending their time in bed and being able to gain more total sleep time, according to a study published in the April 15th issue of the Journal of Clinical Sleep Medicine (JCSM).

16 Apr 2007

Night owls do it tougher than other insomniacs

According to a new study night owls, those who stay up late with insomnia and then sleep longer in the mornings, have more psychological symptoms than morning insomniacs and need different treatment, even though they get more sleep.

16 Apr 2007

A mild head injury can increase your chance of developing a sleep disorder

Researchers say these findings highlight the need for improved diagnosis and treatment of sleep disorders in mild traumatic brain injury patients who complain of insomnia.

4 Apr 2007

Eli Lilly acquires Hypnion

Eli Lilly and Company has announced that it has completed its acquisition of Hypnion, Inc., a privately held neuroscience drug discovery company focused on sleep disorder research.

3 Apr 2007

Fragmented sleep increases spontaneous pain in women

Sleep continuity disturbance impairs endogenous pain-inhibitory function and increases spontaneous pain in women

2 Apr 2007

Actigraphy helps assess and manage sleep disorders

Actigraphy, the use of a portable device that records movement over extended periods of time, and has been used extensively in the study of sleep and circadian rhythms, provides an acceptably accurate estimate of sleep patterns in normal, healthy adult populations and in-patients suspected of certain sleep disorders, according to practice parameters published in the April 1st issue of the journal SLEEP.

2 Apr 2007

Clinical and imaging evidence of Zolpidem effect in hypoxic encephalopathy

A new study reported that zolpidem, a drug normally used to treat insomnia, temporarily improved brain function in a patient suffering from akinetic mutism, a condition in which the person is alert but cannot speak or move.

13 Mar 2007